Final ID: We052
Robinson Christopher, Pattnaik Aryamav, Dhalech Adeeba, Condotta Stephanie, Corn Caleb, Richer Martin, Snell Laura
A Randomized Phase 2 Trial of Muvalaplin: An Oral Disrupter of the Assembly of Lipoprotein(a) ParticlesNicholls Stephen, Ni Wei, Rhodes Grace, Nissen Steven, Navar Ann Marie, Michael Laura, Krege John